Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Canakinumab> ?p ?o }
Showing triples 1 to 99 of
99
with 100 triples per page.
- Canakinumab abstract "Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.Canakinumab was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS) by the U.S. Food and Drug Administration (FDA) on June 2009 and by the European Medicines Agency in October 2009. CAPS is a spectrum of autoinflammatory syndromes including familial cold autoinflammatory syndrome, Muckle–Wells syndrome, and neonatal-onset multisystem inflammatory disease.Canakinumab was being developed by Novartis for the treatment of rheumatoid arthritis but this trial was completed in October 2009. Canakinumab is also in phase I clinical trials as a possible treatment for chronic obstructive pulmonary disease, gout and coronary artery disease. It is also in trials for Schizophrenia. In gout it may result in better outcomes than a low dose of a steroid but costs five thousand times more.".
- Canakinumab atcPrefix "L04".
- Canakinumab atcSuffix "AC08".
- Canakinumab casNumber "914613-48-2".
- Canakinumab drugbank "DB06168".
- Canakinumab fdaUniiCode "37CQ2C7X93".
- Canakinumab thumbnail Canakinumab_bound_to_IL-1β.png?width=300.
- Canakinumab wikiPageID "12148828".
- Canakinumab wikiPageLength "4979".
- Canakinumab wikiPageOutDegree "23".
- Canakinumab wikiPageRevisionID "683568961".
- Canakinumab wikiPageWikiLink Atomic_mass_unit.
- Canakinumab wikiPageWikiLink Category:Novartis.
- Canakinumab wikiPageWikiLink Chronic_obstructive_pulmonary_disease.
- Canakinumab wikiPageWikiLink Clinical_trial.
- Canakinumab wikiPageWikiLink Cold_urticaria.
- Canakinumab wikiPageWikiLink Coronary_artery_disease.
- Canakinumab wikiPageWikiLink Cryopyrin-associated_periodic_syndrome.
- Canakinumab wikiPageWikiLink European_Medicines_Agency.
- Canakinumab wikiPageWikiLink Familial_cold_autoinflammatory_syndrome.
- Canakinumab wikiPageWikiLink Food_and_Drug_Administration.
- Canakinumab wikiPageWikiLink Gout.
- Canakinumab wikiPageWikiLink IL1B.
- Canakinumab wikiPageWikiLink International_Nonproprietary_Name.
- Canakinumab wikiPageWikiLink Intravenous_therapy.
- Canakinumab wikiPageWikiLink KDa.
- Canakinumab wikiPageWikiLink Monoclonal_antibody.
- Canakinumab wikiPageWikiLink Muckle–Wells_syndrome.
- Canakinumab wikiPageWikiLink Neonatal-onset_multisystem_inflammatory_disease.
- Canakinumab wikiPageWikiLink Neonatal_onset_multisystem_inflammatory_disease.
- Canakinumab wikiPageWikiLink Novartis.
- Canakinumab wikiPageWikiLink Rheumatoid_arthritis.
- Canakinumab wikiPageWikiLink Schizophrenia.
- Canakinumab wikiPageWikiLink Subcutaneous_injection.
- Canakinumab wikiPageWikiLink File:Canakinumab_bound_to_IL-1β.png.
- Canakinumab wikiPageWikiLinkText "Canakinumab".
- Canakinumab wikiPageWikiLinkText "Ilaris".
- Canakinumab wikiPageWikiLinkText "canakinumab".
- Canakinumab atcPrefix "L04".
- Canakinumab atcSuffix "AC08".
- Canakinumab c "6452".
- Canakinumab casNumber "914613".
- Canakinumab chembl "1201834".
- Canakinumab chemspiderid "NA".
- Canakinumab drugbank "DB06168".
- Canakinumab h "9958".
- Canakinumab hasPhotoCollection Canakinumab.
- Canakinumab legalUs "Rx-only".
- Canakinumab licenceEu "Ilaris".
- Canakinumab licenceUs "Canakinumab".
- Canakinumab mabType "mab".
- Canakinumab molecularWeight "145.2".
- Canakinumab n "1722".
- Canakinumab o "2010".
- Canakinumab routesOfAdministration Intravenous_therapy.
- Canakinumab routesOfAdministration Subcutaneous_injection.
- Canakinumab s "42".
- Canakinumab source "u".
- Canakinumab target IL1B.
- Canakinumab tradename "Ilaris".
- Canakinumab type "mab".
- Canakinumab unii "37".
- Canakinumab verifiedfields "changed".
- Canakinumab verifiedrevid "460015774".
- Canakinumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Canakinumab wikiPageUsesTemplate Template:Drugbox.
- Canakinumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Canakinumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Canakinumab wikiPageUsesTemplate Template:PDBe.
- Canakinumab wikiPageUsesTemplate Template:Reflist.
- Canakinumab wikiPageUsesTemplate Template:Use_dmy_dates.
- Canakinumab subject Category:Novartis.
- Canakinumab hypernym Antibody.
- Canakinumab type Article.
- Canakinumab type ChemicalSubstance.
- Canakinumab type Company.
- Canakinumab type Drug.
- Canakinumab type Antibody.
- Canakinumab type Article.
- Canakinumab type Chemical.
- Canakinumab type Company.
- Canakinumab type ChemicalObject.
- Canakinumab type Thing.
- Canakinumab type Q8386.
- Canakinumab comment "Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.Canakinumab was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS) by the U.S. Food and Drug Administration (FDA) on June 2009 and by the European Medicines Agency in October 2009.".
- Canakinumab label "Canakinumab".
- Canakinumab sameAs كاناكينوماب.
- Canakinumab sameAs Canakinumab.
- Canakinumab sameAs Canakinumab.
- Canakinumab sameAs Kanakinumab.
- Canakinumab sameAs Canaquinumabe.
- Canakinumab sameAs m.02vrcld.
- Canakinumab sameAs Kanakinumab.
- Canakinumab sameAs Kanakinumab.
- Canakinumab sameAs Q3655009.
- Canakinumab sameAs Q3655009.
- Canakinumab wasDerivedFrom Canakinumab?oldid=683568961.
- Canakinumab depiction Canakinumab_bound_to_IL-1β.png.
- Canakinumab isPrimaryTopicOf Canakinumab.